Med-Chemist : "Quintessential Medicinal Chemistry"
Saturday, September 6, 2014
Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington disease
Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington disease
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment